Odyssey Therapeutics, Inc. · NASDAQ:ODTX
Leiden Jeffrey M bought 5,000 Odyssey Therapeutics, Inc. shares (Form 4)
Traded May 8 to May 11, 2026 · Filed May 11, 2026
From May 8 to May 11, 2026, Leiden Jeffrey M (Director) bought 5,000 Odyssey Therapeutics, Inc. shares at US$20.00 for US$100K, leaving 31,644 shares. Filed May 11, 2026 (Form 4).
- Bought
- 5,000 shares
- Price
- US$20.00
- Value
- US$100K
- Holding after
- 31,644 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | Buy | 5,000 | US$20.00 | 270,198 | Direct |
| May 11, 2026 | Common Stock | Conversion | 28,698 | 28,698 | Indirect | |
| May 11, 2026 | Common Stock | Option exercise | 2,963 | 31,661 | Indirect | |
| May 11, 2026 | Common Stock | Shares withheld for tax | 17 | US$18.00 | 31,644 | Indirect |
Source
Related
- Odyssey Therapeutics, Inc.
- Leiden Jeffrey M
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13G · Lightspeed Venture Partners XV-B (Ignite), L.P. · May 18, 2026
- Schedule 13D · Jeito II S.L.P. · May 15, 2026